EUVIMED · CrossrefJournal
Diabetes Technology & Therapeutics
ISSN 1520-9156 · SAGE Publications
Latest articles
The Varying Benefits of Two Years Automated Insulin Delivery System Use on Continuous Glucose Monitoring Profiles in Children and Adolescents with Type 1 Diabetes
Association Between Cardiorespiratory Fitness and Longitudinal Glycemic Outcomes in Youth with Type 1 Diabetes
Assessing the Utility of a Capillary-Adjusted Oral Glucose Tolerance Test for the Early Detection of Type 1 Diabetes in Childhood
Letter: Response to “Roadmap to Fully Closing the Loop” and Call for a Charter for Consensus Statements in Diabetes
The 2024 National Report on Continuous Glucose Monitoring Uptake in Pediatric Type 1 Diabetes Following Universal Funding in Aotearoa New Zealand: Early Findings from the KiwiDiab Pediatric Diabetes Network
Beyond the Coefficient of Variation: Reframing Glycemic Variability as Dispersion and Volatility
Safety and Effectiveness of MiniMed TM 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes
Cardiovascular, Renal, and Hepatic Biomarkers Outside Guideline-Recommended Thresholds: Prevalence and Determinants in Type 1 Diabetes
Real-World Total Daily Insulin Dose in over 14,000 Young Individuals with Type 1 Diabetes in the United States
Real-World Impact of a National Funding-Driven Transition Between Automated Insulin Delivery Systems in Pediatric Type 1 Diabetes
Glycemic Concordance of Simplera Sync ™ and Instinct ™ Sensors in MiniMed ™ 780G System Users: A Randomized Crossover Feasibility Study
Increased Glycation Ratio and Risk of Complications in Latent Autoimmune Diabetes in Adults Compared With Type 1 Diabetes Onset before 30 Years: A Cohort Study
Glycemic Outcomes and Device Engagement Over 18 Months Following Initiation of Two Different Automated Insulin Delivery Systems in American Youth With Type 1 Diabetes
Response to: Quiros et al.: Baseline Glycemic Control and AID Efficacy in Type 1 Diabetes and Pregnancy
Raising the Bar: High Time in Range During the First Year of Diagnosis of Type 1 Diabetes in Children and Adolescents Using Automated Insulin Delivery with Intense Support
Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes: Outcomes of a Population-Based Real-World Study
Predicting Risk for Diabetic Ketoacidosis in Children Recently Diagnosed with Type 1 Diabetes Using the Risk Index for Diabetic Ketoacidosis
Comparing Automated Lyumjev® Delivery with Carbohydrate Counting, Qualitative Meal-Size Estimation, and Fully Closed-Loop in Type 1 Diabetes: A Pilot, Randomized, Crossover Trial
Real-World MiniMed ™ 780G Advanced Hybrid Closed-Loop Performance Across the Asia-Pacific Region
Efficacy and Safety of the MiniMed™ Vivera™ Algorithm: Results from a First-in-Human Feasibility Trial
Glucose Predictions Improve Glycemic Control: A Digital Twin Evaluation
Early Initiation of Automated Insulin Delivery at Type 1 Diabetes Diagnosis in Children and Adolescents Is Associated with Improved Outcomes
Continuous Glucose Monitoring Hypoglycemia Alarms in Critical Care: Clinical Utility and Workflow Integration
Accuracy of Real-Time Continuous Glucose Monitoring System in Hospitalized Patients with Diabetes and Chronic Kidney Disease
Accuracy of a Continuous Glucose Monitor in the Intensive Care Unit
Continuous Ketone Monitoring in Diabetic Ketoacidosis: Prospective Multicenter Method-Comparison and Feasibility Study
Natural History of Mild Non-Proliferative Diabetic Retinopathy in Adults with Type 1 Diabetes Under Contemporary Diabetes Care
Letter: Impact of Sensor Technical Specifications on Automated Insulin Delivery Performance: Does the Sensor Really not Matter?
Continuous Glucose Monitoring and Automated Insulin Delivery in Infants with Type 1 Diabetes: Real-World Evidence to Support Future International Guidelines
CGM Metrics and the Risk of Pregnancy Complications in Type 1 Diabetes: A Secondary Exploratory Analysis of the CRISTAL Trial
EUVIMED